To enter the phase II trials, patients had to have average sitting diastolic blood pressure (DBP) ≥ 85 mm Hg and ≤ 109 mm Hg. Black patients made up 23% of the total population of the 3 trials. (One ...
Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association's 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...
The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...
A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to switch drug activity on and off inside targeted tissues, potentially ...
For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...